Project: Small and large targeting nanoparticles for treatment of head and neck cancer

Through a complementary consortium, we will provide a preclinical proof-of-concept for an innovative anti-cancer treatment with magnetic hyperthermia, to be used as a basis for subsequent clinical trials on head and neck squamous cell carcinoma (HNSCC). We will deliver small nanoparticles with high targeting efficacy for treatment of metastases and large ones with superior heating efficacy for destruction of primary tumors. We will also use a therapeutic antibody to improve targeting efficiency.

Acronym	Nanoneck2 (Reference Number: 9309)
Duration	01/03/2015 - 01/03/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 2

Project partner

Number	Name	Role	Country
20242	Nanobacterie	Coordinator	France
20243	EPFL	Partner	Switzerland
20244	University of Zurich	Partner	Switzerland